Systematic Identification of Thiosemicarbazides for Inhibition of <i>Toxoplasma gondii</i> Growth In Vitro
One of the key stages in the development of new therapies in the treatment of toxoplasmosis is the identification of new non-toxic small molecules with high specificity to <i>Toxoplasma gondii</i>. In the search for such structures, thiosemicarbazide-based compounds have emerged as a nov...
Main Authors: | Agata Paneth, Lidia Węglińska, Adrian Bekier, Edyta Stefaniszyn, Monika Wujec, Nazar Trotsko, Katarzyna Dzitko |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-02-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/24/3/614 |
Similar Items
-
Discovery of Potent and Selective Halogen-Substituted Imidazole-Thiosemicarbazides for Inhibition of <i>Toxoplasma gondii</i> Growth In Vitro via Structure-Based Design
by: Agata Paneth, et al.
Published: (2019-04-01) -
4-Arylthiosemicarbazide derivatives as a new class of tyrosinase inhibitors and anti-Toxoplasma gondii agents
by: Adrian Bekier, et al.
Published: (2021-01-01) -
Synthesis and In Vitro Anti-<i>Toxoplasma gondii</i> Activity of Novel Thiazolidin-4-one Derivatives
by: Nazar Trotsko, et al.
Published: (2019-08-01) -
1,4-Disubstituted Thiosemicarbazide Derivatives are Potent Inhibitors of Toxoplasma gondii Proliferation
by: Katarzyna Dzitko, et al.
Published: (2014-07-01) -
Inhibition of Toxoplasma gondii by 1,2,4-triazole-based compounds: marked improvement in selectivity relative to the standard therapy pyrimethamine and sulfadiazine
by: Lidia Węglińska, et al.
Published: (2022-12-01)